Stamford Health Launches Pilot Integrating ECG-Based AI for Structural Heart Screening
· GlobeWire Daily Editorial Desk · Source: www.prnewswire.com

Original GlobeWire Daily editorial illustration — not an event photograph.
A new clinical pilot has been launched at Stamford Health in Connecticut to evaluate an artificial intelligence tool designed to screen for structural heart disease and other cardiac conditions using routine electrocardiograms (ECGs).
Project Overview
The initiative brings together healthcare technology company egnite, Pathway Labs, and Stamford Health. It integrates Pathway Labs' recently cleared AI algorithm, known as EchoNext, directly into egnite's CardioCare platform.
- Technology Purpose: EchoNext analyzes 12-lead ECG waveforms to identify signals associated with structural heart conditions, heart failure, and pulmonary hypertension from a single screening.
- Workflow Integration: The CardioCare platform reviews the AI findings alongside the patient's longitudinal electronic health record (EHR) data, including prior history and lab results.
- Objective: To surface pre-qualified patients who may benefit from echocardiographic follow-up and to measure downstream clinical impacts, such as echo completion rates and time to specialist evaluation.
Practical Implications and Implementation
Clinical leaders involved in the project note that while automated screening can identify potential risks, the primary challenge remains ensuring that flagged patients receive timely follow-up without placing an undue burden on clinical staff. By incorporating multiple screening inputs into existing workflows, the CardioCare platform aims to bridge the gap between initial detection and diagnosis.
Funding for the pilot is being supported by Edwards Lifesciences as part of a collaborative effort to promote earlier identification of structural heart conditions.
How to Verify
- Review official press releases and institutional announcements published by Stamford Health, egnite, and Pathway Labs.
- Consult regulatory disclosures regarding the U.S. Food and Drug Administration (FDA) clearance status of the EchoNext algorithm.
- Access published organizational literature through official websites such as StamfordHealth.org and egnitehealth.com.
AI-assisted reporting; source claims are attributed and have not been independently verified.
More to read
Related coverage
Related reporting available at publication.
DeskcommCRM Launches as a Free Open‑Source AI‑Powered Sales OS for WhatsApp‑Based Businesses
Higgsfield AI Launches Markdown-Based Skill Set for Visual Brand Agents
Motty Launches as a Native Go-Based SSH Workspace Without Webview Dependencies
Dubai-Based Director Faisal Hashmi Launches Spine Drop Pictures with Horror Slate
eCloudvalley Renews Strategic Collaboration Agreement with AWS to Drive Enterprise AI Transformation in Asia-Pacific
DoorDash Reports Only 'Several Hundred' Orders From Third-Party AI Agents